Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study

Jong-Mi Seong; Nam-Kyong Choi; Ju-Young Shin; Yoosoo Chang; Ye-Jee Kim; Joongyub Lee; Ju-Young Kim; Byung-Joo Park

doi:10.1371/journal.pone.0124287

Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study

PLoS ONE ◽

10.1371/journal.pone.0124287 ◽

2015 ◽

Vol 10 (5) ◽

pp. e0124287 ◽

Cited By ~ 44

Author(s):

Jong-Mi Seong ◽

Nam-Kyong Choi ◽

Ju-Young Shin ◽

Yoosoo Chang ◽

Ye-Jee Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13636 ◽

2018 ◽

Vol 84 (9) ◽

pp. 2029-2039 ◽

Cited By ~ 13

Author(s):

Wen-Hsuan Hou ◽

Kai-Cheng Chang ◽

Chung-Yi Li ◽

Huang-Tz Ou

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Risk Of Fracture ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Review for "Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial"

10.1111/dom.14254/v2/review4 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Older People ◽

Subgroup Analysis ◽

Dipeptidyl Peptidase ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Review for "Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial"

10.1111/dom.14254/v2/review3 ◽

2020 ◽

Author(s):

Gisle Langslet

Keyword(s):

Type 2 Diabetes ◽

Older People ◽

Subgroup Analysis ◽

Dipeptidyl Peptidase ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Author response for "Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial"

10.1111/dom.14254/v2/response1 ◽

2020 ◽

Author(s):

Mark A. Espeland ◽

Richard E. Pratley ◽

Julio Rosenstock ◽

Takashi Kadowaki ◽

Yutaka Seino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Older People ◽

Subgroup Analysis ◽

Dipeptidyl Peptidase ◽

Cardiovascular Outcomes ◽

Author Response ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial

Diabetology International ◽

10.1007/s13340-020-00447-5 ◽

2020 ◽

Vol 12 (1) ◽

pp. 87-100 ◽

Cited By ~ 1

Author(s):

Takashi Kadowaki ◽

Guang Wang ◽

Julio Rosenstock ◽

Daisuke Yabe ◽

Yongde Peng ◽

...

Keyword(s):

Type 2 Diabetes ◽

Subgroup Analysis ◽

Dipeptidyl Peptidase ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108546 ◽

2021 ◽

Vol 171 ◽

pp. 108546

Author(s):

Chen-Yi Wu ◽

Chun-Ying Wu ◽

Chung-Pin Li ◽

Yiing-Jenq Chou ◽

Yi-Hsian Lin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Decision letter for "Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial"

10.1111/dom.14254/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Older People ◽

Subgroup Analysis ◽

Dipeptidyl Peptidase ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13955 ◽

2019 ◽

Vol 85 (8) ◽

pp. 1719-1727 ◽

Cited By ~ 12

Author(s):

Jong‐Mi Seong ◽

Jeong Yee ◽

Hye Sun Gwak

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

BMJ ◽

10.1136/bmj.k872 ◽

2018 ◽

pp. k872 ◽

Cited By ~ 45

Author(s):

Devin Abrahami ◽

Antonios Douros ◽

Hui Yin ◽

Oriana Hoi Yun Yu ◽

Christel Renoux ◽

...

Keyword(s):

Type 2 Diabetes ◽

Inflammatory Bowel Disease ◽

Cohort Study ◽

Bowel Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Inflammatory Bowel

Download Full-text

Review for "Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial"

10.1111/dom.14254/v2/review2 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Older People ◽

Subgroup Analysis ◽

Dipeptidyl Peptidase ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text